Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Dando

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Gene Therapy|November 1, 2001
A novel human packaging cell line with hematopoietic supportive capacity increases gene transfer into early hematopoietic progenitorsJ S Dando, M G Roncarolo, C Bordignon, et al.
The Journal of Gene Medicine|July 5, 2001
Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cellsJ S Dando, A Aiuti, S Deola, et al.
Journal of Virological Methods|July 1, 1996
Improved detection of replication-competent retrovirusS P Forestell, J S Dando, E Böhnlein, et al.
Journal of Immunological Methods|December 27, 1995
Detection of intracellular HIV-1 Rev protein by flow cytometryR J Rigg, J S Dando, S Escaich, et al.
Virology|April 1, 1996
A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safetyR J Rigg, J Chen, J S Dando, et al.
Gene Therapy|June 1, 1997
Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transferS P Forestell, J S Dando, J Chen, et al.
Leukemia|March 3, 2004
Membrane-bound delta-4 notch ligand reduces the proliferative activity of primitive human hematopoietic CD34+CD38low cells while maintaining their LTC-IC potentialE Lauret, C Catelain, M Titeux, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|November 1, 2001
A novel human packaging cell line with hematopoietic supportive capacity increases gene transfer into early hematopoietic progenitorsJ S Dando, M G Roncarolo, C Bordignon, et al.
The Journal of Gene Medicine|July 5, 2001
Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cellsJ S Dando, A Aiuti, S Deola, et al.
Journal of Virological Methods|July 1, 1996
Improved detection of replication-competent retrovirusS P Forestell, J S Dando, E Böhnlein, et al.
Journal of Immunological Methods|December 27, 1995
Detection of intracellular HIV-1 Rev protein by flow cytometryR J Rigg, J S Dando, S Escaich, et al.
Virology|April 1, 1996
A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safetyR J Rigg, J Chen, J S Dando, et al.
Gene Therapy|June 1, 1997
Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transferS P Forestell, J S Dando, J Chen, et al.
Leukemia|March 3, 2004
Membrane-bound delta-4 notch ligand reduces the proliferative activity of primitive human hematopoietic CD34+CD38low cells while maintaining their LTC-IC potentialE Lauret, C Catelain, M Titeux, et al.
Pageof 1